TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Budget Manipulations “Wreaking Havoc,” Korn Tells NCAB; Legal Actions Being Considered February 13, 1987
